Remove Bacteria Remove Drugs Remove Genotype
article thumbnail

Risk adjusted net present value: What is the current valuation of Pharma Mar’s Ecubectedin?

Pharmaceutical Technology

The drug’s revenue forecasts along with estimated costs are used to measure the value of an investment opportunity in that drug, otherwise known as net present value (NPV). The rNPV model is a more conservative valuation measure that accounts for the risk of a drug in clinical development failing to progress.

Hormones 100
article thumbnail

One world, one health: The interconnected web of antimicrobial resistance

pharmaphorum

Success, then, will rely on an integrated response that focuses on surveillance, stewardship, and intervention accessibility across the spectrum of human, animal, and environmental health, said the report, which was commissioned to assess the progress of the 2014 National Strategy for Combating Antibiotic-Resistant Bacteria. Surveillance.

Medicine 105
article thumbnail

A Globally Rising Burden of Sexually Transmitted Diseases (STDs)

Delveinsight

Caused by bacteria, viruses, and parasites, Sexually transmitted diseases (STDs) are a global health burden and it seems they are likely to maintain their status of being so in coming years also, primarily due to the lack of knowledge, and awareness. The medications can cure some of the STDs caused by bacteria, yeast, or parasites.